Skip to main content
Clinical Trials/NCT05880797
NCT05880797
Recruiting
Not Applicable

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Stanford University1 site in 1 country1,000 target enrollmentJuly 7, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oropharyngeal Carcinoma
Sponsor
Stanford University
Enrollment
1000
Locations
1
Primary Endpoint
Sample collection
Status
Recruiting
Last Updated
19 days ago

Overview

Brief Summary

The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV). For this study, the investigators plan to collect blood from OPC patients prior to treatment and at six subsequent time points.

Registry
clinicaltrials.gov
Start Date
July 7, 2023
End Date
August 1, 2026
Last Updated
19 days ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with oropharyngeal carcinoma or patients with cancer of the unknown primary that is HPV associated, or possibly deemed to be originating from the oropharynx.

Exclusion Criteria

  • Not willing to sign consent

Outcomes

Primary Outcomes

Sample collection

Time Frame: up to 36 months post-op

30-50cc of blood

Sample collection

Time Frame: prior to start of treatment

30-50cc of blood

Secondary Outcomes

  • tumor sample(Day 1)

Study Sites (1)

Loading locations...

Similar Trials